បិទគម្លាតរវាងការស្រាវជ្រាវការរកឃើញ និងការថែទាំអ្នកជម្ងឺ៖ ផ្លូវថតតាមច័ន្ទគតិនៃមហារីក

Note: President Joe Biden in February launched a “Cancer Moonshot” initiative that aims to reduce the death rate from cancer by 50% in the next 25 years. This is part of series of posts with cancer experts offering suggestions to help the Moonshot succeed. The upcoming 3^rd Forbes China Healthcare Summit” នៅថ្ងៃទី 27 ខែសីហា (ថ្ងៃទី 26 ខែសីហា ET) នឹងថ្លែងទៅកាន់ “New International Directions For A Reignited Moonshot” ជាប្រធានបទចម្បងរបស់ខ្លួននៅឆ្នាំនេះ។ ការចុះឈ្មោះគឺឥតគិតថ្លៃ។ សម្រាប់ព័ត៌មានបន្ថែម សូមទំនាក់ទំនង៖ [អ៊ីមែលការពារ]

Dr. Andrea Myers, global program head for lung cancer at Novartis, has been working side by side to help cure patients battling cancer for two decades. It’s important for the Cancer Moonshot initiative not to lose a focus on the delivery and access of care to patients as it seeks grand challenges to advance science, she said in a recent interview.

“The Cancer Moonshot evokes the aspiration of putting someone on the moon, which requires incredible vision and science, but equally important are the tactics and operations,” Myers said. “The process of getting mankind to the moon wasn’t just one of discovering a bigger and better rocket engine. It was the creation of a system in which every component, every bolt, was tested and re-tested to make sure that all the parts and all the people worked together. It was through that process that we were able to get the entire crew both to the moon and back earth safely.

The Cancer Moonshot will involve a system of care stretching from early screening and diagnosis through the completion of care. This system needs to be designed to work well for all people with cancer, individualized to ensure they get the care they need, Myers said.

“Lung cancer is a leading global cancer killer, due in part to its late diagnosis. We now have a screening test available that improves overall survival. Yet it’s cumbersome. Currently, only around 5% of the patients in the United States eligible for the screening actually do it. New, transformative technologies will improve and simplify screening and we should prioritize these advancement efforts. In parallel we need to optimize implementation of what is available now ” she said.

“Often leading edge technological innovations come from institutions with extensive resources, which may not fully reflect the care settings of all patients with cancer and may challenge more broad implementation” noted Myers, formerly a physician at Dana-Faber Cancer Institute and a post-doctorate fellow at Harvard.

“Just like with the original moonshot, every part of the system, every diagnostic and therapeutic needs to be tested in a variety of clinical scenarios. I would love to see creative proposals for how to reach more patients in need than we currently do—it in itself would be lifesaving.”

មើលប្រកាសដែលទាក់ទង៖

ជួបជាមួយអ្នកវិទ្យាសាស្ត្រដែលសំរបសំរួលរឿងមហារីកថ្មីរបស់ Joe Biden

"ហេតុអ្វីបានជាជំងឺមហារីកមិនសូវសំខាន់ក្នុងការព្យាបាលលឿនជាង Covid?": ផ្លូវនៃជំងឺមហារីក

ទម្លុះ​ឧបសគ្គ​ដើម្បី​ជំរុញ​ឲ្យ​មាន​ការ​រីក​ចម្រើន៖ ផ្លូវ​នៃ​ការ​បាញ់​កាំជ្រួច​មហារីក

លោក Biden សមនឹងទទួលបានឥណទានសម្រាប់ការទទួលយកជំងឺមហារីក៖ ផ្លូវនៃការបាញ់ប្រហារមហារីក

@rflannerychina